When associated with rhabdomyolysis in a patient on statin therapy, drug-induced myopathy is one possible cause, but not the only one - as demonstrated in this clinical case. McArdle disease, or glycogen storage disease type V, is a rare metabolic myopathy caused by mutations in the PYGM gene. The gene discussed is PYGM; the disease is myopathy.